ClinicalTrials.Veeva

Menu

The Predictive Value of Retinal Vascular Signs for Intracranial Artery Stenosis (RVS-ICAS)

C

Capital Medical University

Status

Unknown

Conditions

Intracranial Stenosis

Study type

Observational

Funder types

Other

Identifiers

NCT05270746
RVS-ICAS

Details and patient eligibility

About

Intracranial artery stenosis (ICAS) is a leading cause of ischemic stroke worldwide, contributing to the global burden of stroke, particularly in the Asian population. However, there is no non-invasive, easy to popularize and economic for intracranial artery stenosis in mass population screening. This study aims to evaluate the predictive value of retinal vascular signs for intracranial artery stenosis (ICAS) and explore a new screening method.

Full description

Intracranial atherosclerosis stenosis (ICAS) is a leading cause of ischemic stroke worldwide, contributing to the global burden of stroke, particularly in the Asian population. Compared with the other stroke subtypes, patients with ICAS particularly the degree of stenosis≥50% had more severe stroke, stayed longer in the hospital and higher risk of recurrent ischemic events. However, there is no non-invasive, easy to popularize and economic for intracranial artery stenosis in mass population screening. Retinal imaging has great advantages including share the same embryological origin, anatomic features, and physiological properties with brain, non-invasive, easy to popularize, inexpensive and possess good economic benefits. Therefore, investigators design this study to assess the predictive value of retinal vascular signs for intracranial artery stenosis (ICAS) and hope to explore a new screening method.

Enrollment

1,000 estimated patients

Sex

All

Ages

35+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age≥35
  2. Accept TCD examination and fundus examination
  3. Signed informed consent

Exclusion criteria

  1. Non-atherosclerotic stenosis, such as arteritis, moyamoya disease, arterial dissection, vascular malformation, etc., which were clearly diagnosed.
  2. Intracranial space-occupying lesions
  3. Jugular vein and intracranial venous lesions
  4. Patients with severe cardiac, hepatic, renal disease.
  5. Life expectancy of less than 1 year due to co-morbid conditions.
  6. Known pregnancy (or positive pregnancy test), or breast-feeding.
  7. Pathological myopia fundus changes
  8. Glaucoma
  9. Refractive medium turbidity affects fundus observation
  10. Anterior macular membrane of both eyes
  11. Papilledema, optic neuritis and optic neuropathy
  12. Patients who have had internal eye surgery in the last six months (including fundus laser)
  13. Previous history of internal eye trauma
  14. Poor image quality of fundus and images
  15. Any condition which, in the judgment of the investigator, might increase the risk to the patient.

Trial contacts and locations

2

Loading...

Central trial contact

Yuan Gao, MD; Xunming Ji, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems